Germline pathogenic variants in Russian breast cancer patients revealed by whole-genome sequencing

M. V. Nemtsova; Немцова Марина Вячеславовна; M. V. Makarova; Макарова Мария Владимировна; M. M. Byakhova; Бяхова Мария Михайловна; A. M. Danishevich; Данишевич Анастасия Михайловна; O. S. Mishina; Мишина Олеся Сергеевна; M. S. Belenikin; Беленикин Максим Сергеевич; A. A. Krinitsina; Криницына Анастасия Александровна; O. V. Sagaydak; Сагайдак Олеся Владимировна; A. B. Semenova; Семенова Анна Борисовна; Ch. V. Babadzhanova; Бабаджанова Чинчи Владимировна; M. Yu. Shatalova; Шаталова Марина Юрьевна; N. A. Bodunova; Бодунова Наталья Александровна; I. E. Khatkov; Хатьков Игорь Евгеньевич; V. N. Galkin; Галкин Всеволод Николаевич; S. M. Gadzhyeva; Гаджиева Саида Мердановна

doi:10.17650/2313-805X-2026-13-1-72-85

Germline pathogenic variants in Russian breast cancer patients revealed by whole-genome sequencing

Authors: Nemtsova M.V.¹, Makarova M.V.¹, Byakhova M.M.², Danishevich A.M.³, Mishina O.S.¹, Belenikin M.S.¹, Krinitsina A.A.¹, Sagaydak O.V.¹, Semenova A.B.², Babadzhanova C.V.², Shatalova M.Y.², Bodunova N.A.³, Khatkov I.E.³, Galkin V.N.², Gadzhyeva S.M.⁴
Affiliations:
1. LLC “Evogen”
2. City Clinical Hospital named after S.S. Yudin, Moscow Healthcare Department
3. A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department
4. Moscow Healthcare Department
Issue: Vol 13, No 1 (2026)
Pages: 72-85
Section: RESEARCH ARTICLES
Published: 16.03.2026
URL: https://umo.abvpress.ru/jour/article/view/807
DOI: https://doi.org/10.17650/2313-805X-2026-13-1-72-85
ID: 807

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Introduction. In 20–25 % of cases of patients with hereditary forms of breast cancer (BC), pathogenic variants of the BRCA1 and BRCA2 genes predisposing to BC and ovarian cancer can be identified. Based on the results of previous Russian studies, a simple and inexpensive testing system using real-time polymerase chain reaction consisting of the 8 most frequently identified variants (mutations) in the BRCA1 and BRCA2 genes was developed. The use of targeted panels for high-throughput sequencing and whole genome sequencing for diagnosis of hereditary BC led to identification of a number of genes with pathological variants causing this pathology in patients and their relatives.

Aim. To evaluate the profile and frequency of pathological variants in genes associated with tumor development in Russian patients with BC.

Materials and methods. Analysis of the results of whole genome sequencing of samples from 1514 patients with BC and 5163 individuals without oncological diseases (control group) was performed.

Results. A spectrum of mutations in the BRCA1 and BRCA2 genes, as well as pathogenic variants in other genes, were identified. Based on the results of whole genome sequencing a new panel was developed consisting of 10 most common mutations in the BRCA1, BRCA2, АТМ and PALB2 genes. Additionally, significant associations between pathogenic variants in the ATM gene with estrogen-positive luminal BC (р = 0.034) and pathogenic variants in the BRCA1 gene with triple negative BC (p < 0.001) were found.

Conclusion. In accordance with the obtained data, the new panel of the most common pathogenic variants includes BRCA1 (rs28897672, rs80357522, rs80357906, rs41293455, rs80358094), BRCA2 (rs28897756, rs80359604), АТМ (rs587782652) and PALB2 (rs180177143, rs515726123). Implementation of the new extended panel for identification of frequent mutations in Russian patients with BC in clinical practice will allow to identify up to 7.7 % of germline variants in a random sample.

Keywords

breast cancer, hereditary cancer syndrome, hereditary breast cancer, BRCA1, BRCA2, whole genome sequencing, pathogenic variant, common mutations

References

Smolarz B., Nowak A.Z., Romanowicz H. Breast cancer-epidemiology, classification, pathogenesis and treatment (review of literature). Cancers (Basel) 2022;14(10):2569. doi: 10.3390/cancers14102569
Bellanger M., Zeinomar N., Tehranifar P., Terry M.B. Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? J Glob Oncol 2018;4:1–16. doi: 10.1200/JGO.17.00207
Malignant neoplasms in Russia in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 252 p. (In Russ.).
Nielsen F.C., van Overeem Hansen T., Sørensen C.S. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer 2016;16(9):599–612. doi: 10.1038/nrc.2016.72
Zelli V., Compagnoni C., Cannita K. et al. Applications of next generation sequencing to the analysis of familial breast/ovarian cancer. High Throughput 2020;9(1):1. doi: 10.3390/ht9010001
Lavoro A., Scalisi A., Candido S. et al. Identification of the most common BRCA alterations through analysis of germline mutation databases: is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? Int J Oncol 2022;60(5):58. doi: 10.3892/ijo.2022.5349
Bateneva E.I., Filipova M.G., Tyluydina A.S. et al. Results of genetic screening of the BRCA1 and BRCA2 gene germline mutations in breast cancer patients and ovarian cancer patients in the Russian population. Onkoginekogogiya = Oncogynecology 2015;3:34–9 (In Russ.).
Online Mendelian Inheritance in Man. Available at: https://omim.org
National Center for Biotechnology Information. Available at: https://www.ncbi.nlm.nih.gov/.
VarSome. The Human Genomics Community. Available at: https://varsome.com/.
Richards S., Aziz N., Bale S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17(5):405–24. doi: 10.1038/gim.2015.30
Daly M.B., Pal T., Maxwell K.N. et al. NCCN guidelines® insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024. J Natl Compr Canc Netw 2023;21(10):1000–10. doi: 10.6004/jnccn.2023.0051
Breast Cancer Association Consortium. Breast cancer risk genes – association analysis in more than 113,000 women. N Engl J Med 2021;384(5):428–39. doi: 10.1056/NEJMoa1913948
Wendt C., Margolin S. Identifying breast cancer susceptibility genes: a review of the genetic background in familial breast cancer. Acta Oncol 2019;58(2):135–46. doi: 10.1080/0284186X.2018.1529428
Apostolou P., Fostira F., Papamentzelopoulou M. et al. CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases. Cancer Genet 2015;208(4):129–34. doi: 10.1016/j.cancergen.2015.02.006
Breast cancer. Clinical recommendations of the Ministry of Health of Russia. (In Russ.). Available at: https://oncology-association.ru/wp-content/uploads/2021/02/rak-molochnoj-zhelezy-2021.pdf
Wunderle M., Gass P., Häberle L. et al. BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients. Breast Cancer Res Treat 2018;171(1):85–94. doi: 10.1007/s10549-018-4797-8
Pavese F., Capoluongo E.D., Muratore M. et al. BRCA mutation status in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: a pivotal role for treatment decision-making. Cancers (Basel) 2022;14(19):4571. doi: 10.3390/cancers14194571
Seca M., Narod S.A. Breast cancer and ATM mutations: treatment implications. Hered Cancer Clin Pract 2024;22(1):26. doi: 10.1186/s13053-024-00300-9
Najnin R.A., Al Mahmud M.R., Rahman M.M. et al. ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen. Cell Rep 2023;42(1):111909. doi: 10.1016/j.celrep.2022.111909

Supplementary files

Supplementary Files

Action

1. JATS XML

Download

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

Germline pathogenic variants in Russian breast cancer patients revealed by whole-genome sequencing

Full Text

Abstract

Keywords

About the authors

References

Supplementary files